![]() |
市場調查報告書
商品編碼
1930034
骨填充材料市場規模、佔有率、成長及全球產業分析:按類型、應用和地區劃分的洞察與預測(2025-2034)Bone Void Fillers Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2025-2034 |
||||||
全球骨填充材料市場預計在2025年達到37.3億美元,並在2026年達到39.7億美元。報告顯示,該市場預計將持續穩定成長,到2034年達到67.4億美元,在預測期(2026-2034年)內複合年增長率(CAGR)為6.8%。
北美地區在2025年將佔全球市場47.3%的佔有率,這主要得益於該地區骨科手術量大以及主要生產商的強大影響力。
骨填充物(BVF)是一種生物相容性、生物活性、可吸收且具有骨傳導性的材料,用於填充四肢、骨盆和脊椎等部位的骨缺損。這些材料能夠提供結構穩定性並促進骨再生,在骨科、創傷和脊椎手術中發揮至關重要的作用。
市場驅動因素
骨病變和骨折的日益增加
骨腫瘤、骨髓炎、骨折和創傷性損傷的盛行率不斷上升是推動市場成長的主要因素。全球人口快速老化,導致骨質疏鬆症和骨折風險增加,進一步加速了對骨填充物的需求。這些產品廣泛用於治療慢性骨髓炎,而釋放抗生素的填充物已顯示出改善臨床療效的效果。
合成骨填充材料的日益普及
合成填充材料,如硫酸鈣和磷酸三鈣,因其諸多優勢而迅速普及,包括高度無菌、供應無限、降低供體部位併發症風險以及與人體骨骼化學成分相似。 2020年,BONESUPPORT AB公司的CERAMENT產品獲得FDA批准,進一步推動了合成填充材料的全球應用。
此外,可釋放抗生素的骨填充材料兼具抗菌和骨傳導的雙重功效,可降低骨科感染的發生率,並進一步促進市場擴張。
市場趨勢
對可釋放抗生素填充材料的日益關注
影響市場發展的關鍵趨勢之一是人們對用於預防術後感染的可釋放抗生素的骨填充材料的興趣日益濃厚。 2022年,BONESUPPORT AB的抗生素預混填充劑獲得監管部門批准,Elute Inc.的妥布黴素預混EP顆粒獲得FDA批准進行臨床試驗。預計這些創新將在預測期內顯著推動市場成長。
市場限制因子
儘管成長前景強勁,但由於臨床應用限制和骨缺損填充劑使用不廣泛,市場仍面臨挑戰。組織反應、骨形成不完全、感染和產品破損等風險限制了部分地區的採用。
此外,FDA的產品召回事件,例如2021年OSTEOVATION RMX的召回,對市場信心造成了負面影響。自體移植和異體移植等傳統外科技術的持續廣泛應用進一步限制了市場滲透率。
按類型
脫礦骨基質 (DBM) 細分市場佔最大的市場佔有率,預計由於其豐富的供體來源、更快的癒合速度和更少的併發症,將繼續保持其主導地位。
硫酸鈣細分市場預計將以最高的複合年增長率成長,這主要歸功於其抗菌特性以及在骨髓炎治療中日益廣泛的應用。膠原蛋白基質填充劑也因其易於使用和快速恢復而備受關注。
依型態
到 2025 年,糊狀填充劑將佔市場主導地位,約佔 33% 的市場佔有率。這主要得益於其在脊椎和骨科手術中的高應用率。糊狀和顆粒狀填充劑也因其生物相容性的提高和良好的臨床效果而不斷增長。
依最終使用者劃分
到 2026 年,醫院將佔最大的市場佔有率,達到 54.91%,這主要得益於其高骨科手術量和先進的手術基礎設施。預計專科診所在預測期內也將穩定成長。
The global bone void fillers market was valued at USD 3.73 billion in 2025 and is projected to reach USD 3.97 billion in 2026. According to the report, the market is expected to grow steadily and attain a value of USD 6.74 billion by 2034, registering a compound annual growth rate (CAGR) of 6.8% during the forecast period (2026-2034).
In 2025, North America dominated the global market with a share of 47.3%, supported by a high volume of orthopedic procedures and the strong presence of leading manufacturers.
Bone Void Fillers (BVFs) are biocompatible, bioactive, absorbable, and osteoconductive materials used to fill bone gaps in areas such as extremities, pelvis, and the spine. These materials provide structural stability and promote bone regeneration, making them essential in orthopedic, trauma, and spinal surgeries.
Market Drivers
Rising Burden of Bone Diseases and Fractures
The increasing prevalence of bone tumors, osteomyelitis, fractures, and trauma injuries is a major factor driving market growth. A rapidly aging global population, which is more prone to osteoporosis and fractures, is further accelerating demand for bone void fillers. These products are widely used in the treatment of chronic osteomyelitis, where antibiotic-eluting fillers have shown improved clinical outcomes.
Growing Adoption of Synthetic Bone Void Fillers
Synthetic fillers such as calcium sulfate and tri-calcium phosphate are witnessing strong adoption due to advantages like high sterility, unlimited supply, reduced donor-site morbidity, and chemical similarity to human bone. In 2020, BONESUPPORT AB received FDA approval for CERAMENT, strengthening the adoption of synthetic fillers globally.
Additionally, antibiotic-eluting bone void fillers offer combined antimicrobial and osteoconductive benefits, reducing orthopedic infection rates and driving further market expansion.
Market Trends
Increasing Focus on Antibiotic-Eluting Fillers
One of the key trends shaping the market is the growing focus on antibiotic-eluting bone void fillers to prevent post-surgical infections. In 2022, BONESUPPORT AB received regulatory approvals for antibiotic-mixed fillers, while Elute, Inc. obtained FDA authorization for clinical trials of EP Granules with Tobramycin. Such innovations are expected to significantly boost market growth during the forecast period.
Market Restraints
Despite strong growth prospects, the market faces challenges due to clinical limitations and under-penetration of bone void fillers. Risks such as adverse tissue reactions, incomplete bone formation, infections, and product breakage have limited adoption in some regions.
Moreover, FDA product recalls, such as the recall of OSTEOVATION RMX in 2021, have negatively impacted market confidence. Traditional procedures like autografts and allografts remain widely used, further restricting market penetration.
By Type
The demineralized bone matrix (DBM) segment held the largest market share and is expected to maintain its dominance due to abundant donor availability, faster healing, and reduced complications.
The calcium sulfate segment is projected to grow at the fastest CAGR due to its antibiotic properties and increasing use in osteomyelitis treatment. Collagen matrix fillers are also gaining traction because of ease of use and faster recovery.
By Form
The putty segment dominated the market in 2025, accounting for approximately 33% share, driven by high adoption in spinal and orthopedic procedures. Paste and granule forms are also expanding due to improved biocompatibility and favorable clinical outcomes.
By End User
Hospitals accounted for the largest market share, 54.91% in 2026, due to the high volume of orthopedic surgeries and availability of advanced surgical infrastructure. Specialty clinics are also expected to grow steadily during the forecast period.
Competitive Landscape
Key players include Zimmer Biomet, Stryker, DePuy Synthes, BONESUPPORT AB, Biocomposites, and Collagen Matrix. Market leaders are focusing on product launches, mergers & acquisitions, and geographic expansion to strengthen their market position.
Conclusion
In conclusion, the bone void fillers market is set for steady growth, increasing from USD 3.73 billion in 2025 to USD 6.74 billion by 2034. Growth is driven by rising orthopedic procedures, increasing bone disease burden, and strong innovation in synthetic and antibiotic-eluting fillers. While clinical risks and product recalls remain challenges, continuous R&D, regulatory approvals, and expanding applications are expected to sustain long-term market expansion.
Segmentation By Type
By Form
By End-user
By Region